Caspase 3 and 8 deficiency in human neuroblastoma

Cancer Genetics and Cytogenetics

Volumn 146, Issue 1, 2003, Pages 41-47

  Iolascon, Achille ^a   Borriello, Adriana ^b   Giordani, Lucia ^c   Cucciolla, Valeria ^b   Moretti, Arcangela ^c   Monno, Fausta ^c   Criniti, Vittoria ^b   Marzullo, Andrea ^c   Criscuolo, Maria ^b   Della Ragione, Fulvio ^b  

^a UNIVERSITY OF FOGGIA   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; MESSENGER RNA; PROTEIN;

APOPTOSIS; ARTICLE; CANCER STAGING; CONTROLLED STUDY; ENZYME DEFICIENCY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NEUROBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE; STATISTICAL SIGNIFICANCE;

EID: 0141453653     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00125-0     Document Type: Article

References (27)

1. Hannum Y.A. Apoptosis and the dilemma of cancer chemotherapy. Blood. 89:1997;1845-1853.
2. Sayers T.J., Brooks A.D., Lee J.K., Fenton R.G., Komschlies K.L., Wigginton J.M., Winkler-Pickett R., Wintrout R.H. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contribution of perforin-dependent versus Tas-mediated pathways in lysis by NK and T cells. J Immunol. 161:1998;3957-3965.
3. Earnshaw W.C. Nuclear changes in apoptosis. Curr Opin Cell Biol. 7:1995;337-343.
4. Slee E.A., Harte M.T., Kluck R.M., Wolf B.B., Casiano C.A., Newmeyer D.D., Wang H.G., Reed J.C., Nicholson D.W., Alnemri E.S., Gree D.R., Martin S.J. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspase-2, -3, -6, -7, 8 and -10 in a caspase-9-dependent manner. J Cell Biol. 144:1999;281-292.
5. Gottlieb T.M., Oren M. p53 and apoptosis. Semin Cancer Biol. 8:1998;359-368.
6. Housman D.E., Jacks T. p53 status and the efficacy of cancer therapy in vivo. Science. 266:1994;807-810.
7. Martinez-Lorenzo M.J., Gamen S., Etxeberria J., Lasierra P., Larrad L., Pineiro A., Anel A., Naval J., Alava M.A. Resistance to apoptosis correlates with a highly proliferative phenotype and loss of Fas and CPP32 (caspase-3) expression in human leukemia cells. Int J Cancer. 75:1998;473-481.
8. Strobel P., Nanan R., Gattenlohner S., Muller-Deubert S., MullerHermelink H.K., Kreth H.W., Marx A. Reversible monoclonal lymphoadenopathy in autoimmune lymphoproliferative syndrome with functional FAS (CD95/APO-1) deficiency. Am J Surg Pathol. 23:1999;829-837.
9. Coustan-Smith E., Kitanaka A., Pui C.H., McNinch L., Evans W.E., Raimondi S.C., Behm F.G., Arico M., Campana D. Clinical relevance of Bcl-2 overexpression in childhood acute lymphoblastic leukemia. Blood. 87:1996;1240-1246.
10. Janicke R.U., Sprengart M.L., Wati M.R., Porter A.G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem. 273:1998;9357-9360.
11. Teitz T., Wei T., Valentine M.B., Vanin E.F., Grenet J., Valentine V.A., Behm F.G., Look A.T., Lahti J.M., Kidd V.J. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med. 6:2000;529-535.
12. Teitz T., Lahti J.M., Kidd V.J. Aggressive childhood neuroblastomas do not express caspase-8: an important component of programmed cell death. J Mol Med. 79:2001;428-436.
13. Takita J., Yang H.W., Bessho F., Hanada R., Yamamoto K., Kidd V.J., Teitz T., Wei T., Hayashi Y. Absent or reduced expression of the caspase 8 gene occurs frequently in neuroblastoma, but not commonly in Ewing sarcoma or rhabdomyosarcoma. Med Pediatr Oncol. 35:2000;541-543.
14. Hopkins-Donaldson S., Bodmer J.L., Bourloud K.B., Brognara C.B., Tschopp J., Gross N. Loss of caspase-8 expression in neuroblastoma is related to malignancy and resistance to TRAIL-induced apoptosis. Med Pediatr Oncol. 35:2000;608-611.
15. Zuzak T.J., Steinhoff D.F., Sutton L.N., Phillips P.C., Eggert A., Grotzer M.A. Loss of caspase-8 mRNA expression is common in childhood primitiveneuroectodermal brain tumour/medulloblastoma. Eur J Cancer. 38:2002;83-91.
16. Fulda S., Kufer M.U., Meyer E., van Valen F., Dockhorn-Dworniczak B., Debatin K.M. Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Oncogene. 20:2001;5865-5877.
17. Shivapurkar N., Toyooka S., Eby M.T., Huang C.X., Sathyanarayana U.G., Cunningham H.T., Reddy J.L., Brambilla E., Takahashi T., Minna J.D., Chaudhary P.M., Gazdar A.F. Differential inactivation of caspase-8 in lung cancer. Cancer Biol Ther. 1:2002;65-69.
18. Brodeur G.M., Pritchard J., Berthold F., Carlsen N.L., Castel V., Castelberry R.P., De Bernardi B., Evans A.E., Favrot M., Hedborg F. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J Clin Oncol. 8:1993;1466-1477.
19. Tonini G.P., Boni L., Pession A., Rogers D., Iolascon A., Basso G., Cordero di Montezemolo L., Casale F., Pession A., Perri P., Mazzocco K., Scaruffi P., Lo Cunsolo C., Marchese N., Milanaccio C., Conte M., Bruzzi P., De Bernardi B. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children. J Clin Oncol. 15:1997;85-93.
20. INK4 deficiency in multiple tumor cell lines. Oncogene. 10:1995;827-833.
21. INK4- and p18-containing complexes in human cell lines. J Biol Chem. 271:1996;15942-15949.
22. Della Ragione F., Cucciolla V., Borriello A., Della Pietra V., Manna C., Galletti P., Zappia V. Pyrrolidine dithiocarbamate induces apoptosis by a cytochrome c-dependent mechanism. Biochem Biophys Res Commun. 268:2000;942-946.
23. Iolascon A., Giordani L., Borriello A., Carbone R., Izzo A., Tonini G.P., Gambini C., Della Ragione F. Reduced expression of transforming growth factor-beta receptor type III in high stage neuroblastomas. Br J Cancer. 82:2000;1171-1176.
24. Iolascon A., Giordani L., Moretti A., Basso G., Borriello A., Della Ragione F. Analysis of CDKN2A, CDKN2B, CDKN2C and cyclin Ds gene status in hepatoblastoma. Hepatology. 27:1998;989-995.
25. Kolenko V., Uzzo R.G., Bukowski R., Bander N.H., Novick A.C., His E.D., Finke J.H. Dead or dying: necrosis versus apoptosis in caspase-deficient human renal cell carcinoma. Cancer Res. 59:1999;2838-2842.
26. Ding H.-F., Lin Y.-L., McGill G., Juo P., Zhu H., Blenis J., Yuan J., Fisher D.E. Essential role for caspase-8 in transcription-independent apoptosis triggered by p53. J Biol Chem. 275:2000;38905-38911.
27. Adida C., Berrebi D., Peuchmaur M., Reyes-Mugica M., Altieri D.C. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet. 351:1998;882-883.